羧酸酯酶研究进展

哺乳动物羧酸酯酶carboxylesterase(EC3.1.1.1)组成一个多基因家族,其基因产物定位于多种组织的内质网中。羧酸酯酶能有效地催化酯类和酰胺类化合物水解,属丝氨酸水解酶家族。羧酸酯酶与多种药物、环境毒物及致癌物的解毒和代谢有关,并参与脂质运输和代谢。作者详细介绍了羧酸酯酶的生化性质、作用机理及其分子生物学方面的最新进展。     

运用α-氰代酯荧光底物检测抗性棉蚜羧酸酯酶代谢活性

为了研究抗性和敏感棉蚜Aphis gossypii品系对菊酯类药剂代谢的差异, 本实验合成了溴氰菊酯和高效氯氰菊酯报告荧光底物, 应用这两种底物水解后生成具有荧光化合物的特性,测定了不同品系棉蚜羧酸酯酶的代谢活性。结果表明: 氧化乐果棉蚜抗性和敏感品系羧酸酯酶对溴氰菊酯报告荧光底物的代谢活性分别为10.0和3.4 pmol/min·mg; 对高效氯氰菊酯报告荧光底物的代谢活性分别为4.0和2.4 pmol/min·mg, 抗性品系羧酸酯酶对溴氰菊酯和高效氯氰菊酯报告荧光底物的代谢活性分别为敏感品系的2.9和1.7倍; 溴氰菊酯棉蚜抗性和敏感品系羧酸酯酶对溴氰菊酯报告荧光底物的代谢活性分别为7.6和6.2 pmol/min·mg; 对高效氯氰菊酯报告荧光底物的代谢活性分别为9.3和5.2 pmol/min·mg, 抗性品系羧酸酯酶对溴氰菊酯和高效氯氰菊酯报告荧光底物的代谢活性分别为敏感品系的1.2和1.8倍。这种衍生的报告荧光底物能够用来检测抗性棉蚜羧酸酯酶的水解活性, 表明羧酸酯酶可能参与棉蚜对溴氰菊酯和氧化乐果抗性的形成。     

溴氰菊酯对飞蝗羧酸酯酶基因表达的影响

【目的】研究溴氰菊酯作用下飞蝗羧酸酯酶基因的mRNA表达特性,为溴氰菊酯的代谢解毒及飞蝗Locusta migratoria防治中抗性风险的评估提供基础资料。【方法】本文采用不同剂量溴氰菊酯处理3龄飞蝗,提取总RNA,体外反转录合成cDNA模板,采用Real-time PCR技术分析飞蝗羧酸酯酶基因在溴氰菊酯不同浓度和不同时间处理后的表达模式。【结果】飞蝗经不同浓度溴氰菊酯处理12 h后,LmCesA3和LmCesE1表现为诱导效应;除LmCesA2外,其余羧酸酯酶基因经溴氰菊酯LD30剂量处理后分别在不同的时间点表现为诱导效应。【结论】5个羧酸酯酶基因LmCesA1、LmCesA3、LmCesD1、LmCesE1和LmCesI1可以被溴氰菊酯诱导,表明其可能参与飞蝗对溴氰菊酯的代谢解毒及抗性产生。     

东亚飞蝗羧酸酯酶基因的克隆和原核表达

羧酸酯酶是昆虫体内重要的代谢解毒酶系,其主要功能是水解和结合内源性和外源性含有酯键的有毒物质,减缓其到达靶标部位的时间。东亚飞蝗Locusta migratoria manilensis(Meyen)是我国重要的农业害虫,对其羧酸酯酶基因克隆和表达有助于深入探索杀虫剂代谢毒理机制。本研究首先对羧酸酯酶基因(CarE4)进行了克隆,并将其插入到pCold TF DNA Vector中,在大肠杆菌中进行了原核表达,最后用疏水层析和离子交换层析方法对目的蛋白进行了纯化。本文成功建立了羧酸酯酶蛋白原核表达和纯化技术体系,为进一步研究东亚飞蝗羧酸酯酶的生理功能、结构特点和作用原理提供了基础资料。     

Cloning and prokaryotical expression of CarE gene in Locusta migratoria manilensis

羧酸酯酶是昆虫体内重要的代谢解毒酶系,其主要功能是水解和结合内源性和外源性含有酯键的有毒物质,减缓其到达靶标部位的时间.东亚飞蝗Locusta migratoria manilensis (Meyen)是我国重要的农业害虫,对其羧酸酯酶基因克隆和表达有助于深入探索杀虫剂代谢毒理机制.本研究首先对羧酸酯酶基因(CarE4)进行了克隆,并将其插入到pCold TF DNA Vector中,在大肠杆菌中进行了原核表达,最后用疏水层析和离子交换层析方法对目的蛋白进行了纯化.本文成功建立了羧酸酯酶蛋白原核表达和纯化技术体系,为进一步研究东亚飞蝗羧酸酯酶的生理功能、结构特点和作用原理提供了基础资料.     

星豹蛛四个羧酸酯酶基因克隆及溴氰菊酯胁迫下的表达模式

【目的】探究星豹蛛Pardosa astrigera羧酸酯酶基因PaCarE1-4是否与其代谢溴氰菊酯有关。【方法】采用RT-PCR技术克隆星豹蛛4个羧酸酯酶基因PaCarE1-4 cDNA序列,通过生物信息学软件分析其序列特性。采用RT-qPCR技术测定这4个羧酸酯酶基因在星豹蛛雌雄成蛛不同组织(头胸部、腹部和足)以及在不同浓度(LC₁₀=5.151 mg/L; LC₃₀=8.619 mg/L; LC₅₀=12.311 mg/L)溴氰菊酯胁迫12 h和LC₃₀浓度溴氰菊酯胁迫2, 4, 8, 12, 24和48 h雄成蛛中的相对表达水平。【结果】克隆获得星豹蛛羧酸酯酶基因PaCarE1-4(GenBank登录号分别为MZ643212, MZ643214, MZ643215和 MZ643216)的全长cDNA序列,开放阅读框(ORF)分别长1 653, 1 803, 1 827和1 818 bp,分别编码550, 600, 608和605个氨基酸。组织表达谱结果表明,PaCarE1和PaCarE2在星豹蛛雌雄成蛛腹部中的表达量最高,且在雄成蛛腹部中的表达量高于雌成蛛中的;PaCarE3和PaCarE4在雌雄成蛛头胸部中的表达量最高,且PaCarE3在雌成蛛头胸部中的表达量高于雄成蛛中的,PaCarE4在雄成蛛头胸部中的表达量高于雌成蛛中的。LC₃₀浓度溴氰菊酯胁迫12 h诱导了星豹蛛雄成蛛中PaCarE1的表达,LC₁₀和LC₃₀浓度溴氰菊酯胁迫12 h诱导了PaCarE2的表达。LC₃₀浓度溴氰菊酯胁迫不同时间后,与对照组(丙酮处理组)相比,星豹蛛雄成蛛中PaCarE4的表达量与对照组均无显著差异,而PaCarE1的表达量在处理后2, 8和12 h, PaCarE2的表达量在处理后12 h,以及PaCarE3的表达量在处理后24 h显著上调。【结论】羧酸酯酶基因PaCarE1, PaCarE2和PaCarE3可以被溴氰菊酯诱导表达,表明其可能参与星豹蛛对溴氰菊酯的代谢过程。本研究结果有助于了解星豹蛛对外源物质的代谢机理,为这一捕食性天敌的保护提供了新思路。     

光呼吸途径及其功能

光呼吸是C3植物体内重要的代谢过程,是光合作用研究的热点之一。本文阐述了光呼吸的正常代谢途径及乙醛酸代谢的交替途径,交替途径的功能,及途径中关键酶的生物学特性。就光呼吸在减轻逆境伤害、减缓叶绿素的降解、驱动卡尔文循环、参与三羧酸循环、氮素代谢、蛋白质积累以及PSI和PSⅡ之间的状态转换等生物学功能进行了综述。     

单羧酸转运蛋白家族及其生物学功能

单羧酸转运蛋白家族是哺乳动物细胞膜上一类重要的跨膜转运蛋白,负责乳酸,短链脂肪酸等单羧酸类化合物的跨膜转运,涉及多种生物学功能,包括促进营养物质吸收、影响代谢动态平衡、调节胞内pH值以及参与药物输送等.迄今为止,单羧酸转运蛋白家族已发现有1 4个成员,各亚型间具有底物差异性和组织分布特异性.研究单羧酸转运蛋白家族的生化特征、组织分布、生物学功能及基因表达调控,将为人和动物的营养代谢稳衡和疾病治疗提供新的方法.     

乙基多杀菌素抗性小菜蛾代谢解毒酶酶活性研究

【目的】阐明小菜蛾Plutella xylostella(L.)对乙基多杀菌素的代谢抗性机理,为延缓小菜蛾对乙基多杀菌素抗药性发展及抗性治理技术提供支持。【方法】通过酶动力学方法测定了小菜蛾对乙基多杀菌素高抗、中抗和敏感种群的谷胱甘肽-S-转移酶、羧酸酯酶、乙酰胆碱酯酶和多功能氧化酶4种代谢解毒酶的比活力。【结果】乙基多杀菌素高抗小菜蛾种群的谷胱甘肽-S-转移酶、羧酸酯酶、乙酰胆碱酯酶的比活力分别为15.38、3.15和7.30 OD·min~(-1)·mg~(-1)pro,显著高于敏感种群;但乙酰胆碱酯酶在中抗种群和敏感种群中比活力差异不显著;多功能氧化酶在高抗、中抗和敏感种群中的比活力分别为4.97、4.08和4.23 OD·min~(-1)·mg~(-1)pro,差异不显著。【结论】谷胱甘肽-S-转移酶、羧酸酯酶和乙酰胆碱酯酶的酶活随着小菜蛾对乙基多杀菌素抗性的增强而增强,而多功能氧化酶的酶活在抗性种群与敏感种群间差异不显著,因此小菜蛾对乙基多杀菌素的代谢抗性机理研究应重点关注这3种酶。     

棉铃虫羧酸酯酶基因的克隆、序列分析及组织表达

为了从分子水平上研究棉铃虫Helicoverpa armigera (Hübner) 对杀虫剂抗性的产生机理,本文通过RT PCR和RACE方法首次从棉铃虫中肠中克隆了一个羧酸酯酶全长cDNA序列。序列分析表明,该基因包含一个1 794 bp的开放读码框,129 bp的5′UTR和139 bp的3′UTR区域。该基因编码597个氨基酸, 推测编码蛋白质的等电点pI为4.92,分子量为67.1 kD,GenBank登录号为EF547544。通过对氨基酸的同源性分析表明,该羧酸酯酶与斜纹夜蛾Spodoptera litura羧酸酯酶的同源性最高,达60%。半定量RT-PCR分析表明,该基因在中肠组织中表达量最高,在脂肪体和生殖腺中表达量较低,在头部则不表达。推测该羧酸酯酶基因可能主要参与棉铃虫对外源物质的解毒代谢。     

Effect of HCV infection on THP-1 monocytoid cells

Hepatitis C virus (HCV) is the main cause of hepatocellular carcinoma in industrialized countries. HCV-HIV-1 co-infection occurs frequently among users of illicit intravenous drugs, thereby increasing the severity of HIV disease and the evolution of chronic active hepatitis towards cirrhosis and hepatocellular carcinoma. The present work shows that THP-1 monocytoid cells are susceptible to HCV infection, of strain 1b, and that this strain can induce cellular modifications in this cell line. Infection of HCV was demonstrated by positivity for the E2 antigen within THP-1 cells and by indirect immunofluorescence; moreover, HCV-RNA was detected in supernatants of THP-1 cells from day 7 post-inoculation. Cell shape and membrane surface antigens varied upon viral infection, which is also capable of inducing oxygen radicals. In particular we underline the relevant intracellular accumulation of ferritin that paralleled an increase of cell surface expression of the transferrin receptor. Evaluation of cellular events upon HCV infection in THP-1 cells may represent a useful tool with which to identify alteration in monocytes metabolism and to study therapeutic approaches for such alterations.     

血色病的临床与基础研究进展

遗传性血色病（Hereditary Hemochromatosis,HH）是一种西方常见的遗传性铁过载性疾病。目前已知的血色病基因主要包括剧硒、YfR2、HJV、FPN及HAMP。这些基因突变导致大量铁离子逐渐沉积在肝、心、胰腺等脏器的实质细胞,造成组织纤维化和结构改变,最终引起器官功能障碍和衰竭,常见症状有肝硬化、肝癌、糖尿病、心力衰竭、垂体及性腺功能减退、关节疾病和皮肤色素沉着等。当前,机体铁代谢分子机制研究的飞速发展,为深入了解血色病带来了契机。综合铁代谢研究领域最新进展,着重对血色病发展历程、发病机制、临床表现、诊断、治疗及中国血色病现状等方面展开综述。     

Caveolin enhances hepatocellular carcinoma cell metabolism,migration, and invasion in vitro via a hexokinase 2-dependent mechanism

The development and progression of hepatocellular carcinoma (HCC) have been associated with abnormal cellular metabolism. Gene Expression Profiling Interactive Analysis RNA sequencing data revealed caveolin-1 (CAV-1) and hexokinase 2 (HK2) messenger RNA (mRNA) were significantly upregulated in human HCC compared with normal tissues, and high HK2 expression was associated with significantly poorer overall survival in HCC ( p < 0.05). CAV-1 and HK2 mRNA and protein expression were upregulated and positively correlated in 42 fresh human HCC tissues compared with tumor-adjacent normal tissues. Overexpression of CAV-1 or HK2 in SMMC-7721 and HepG2 HCC cells enhanced glucose and lactate metabolism and increased cell migration and invasion in transwell assays; knocking down CAV-1 or HK2 had the opposite effects. Overexpression of CAV-1 increased HK2 expression; overexpression of HK2 did not affect CAV-1 expression. Knocking down HK2 partially reversed the ability of CAV-1 to promote cellular metabolism, invasion, and migration in HCC, indicating CAV-1 enhances glycolysis, invasion, and metastasis in HCC cells via HK2-dependent mechanism. Further studies of the function and relationship between CAV-1 or HK2 expression are warranted to explore the potential of these proteins as metabolic targets for the treatment of HCC.     

Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil

Human carboxylesterase 1 (hCE1) exhibits broad substrate specificity and is involved in xenobiotic processing and endobiotic metabolism. We present and analyze crystal structures of hCE1 in complexes with the cholesterol-lowering drug mevastatin, the breast cancer drug tamoxifen, the fatty acyl ethyl ester (FAEE) analogue ethyl acetate, and the novel hCE1 inhibitor benzil. We find that mevastatin does not appear to be a substrate for hCE1, and instead acts as a partially non-competitive inhibitor of the enzyme. Similarly, we show that tamoxifen is a low micromolar, partially non-competitive inhibitor of hCE1. Further, we describe the structural basis for the inhibition of hCE1 by the nanomolar-affinity dione benzil, which acts by forming both covalent and non-covalent complexes with the enzyme. Our results provide detailed insights into the catalytic and non-catalytic processing of small molecules by hCE1, and suggest that the efficacy of clinical drugs may be modulated by targeted hCE1 inhibitors.     

Altered glycosaminoglycan composition in reactive and neoplastic human liver

We have investigated the glycosaminoglycan composition of normal human liver, focal nodular hyperplasia, hepatic adenoma, and hepatocellular carcinoma. Uronic acid increased about 4 fold in the benign and reactive lesions, and greater than 7 fold in the carcinoma. Whereas in focal nodular hyperplasia and adenoma dermatan sulfate was the predominant glycosaminoglycan, in hepatocellular carcinoma chondroitin sulfate was the predominant species; it increased 24 fold over normal liver and 3-5 fold over all the other tissues. HPLC analysis of chondroitinase ABC or AC digests showed a 58 fold increase in Delta-Di-OS disaccharides in hepatocellular carcinoma, indicating significant undersulfation of chondroitin sulfate. Surprisingly, the normal-appearing liver surrounding the carcinoma showed glycosaminoglycan changes similar to adenoma and nodular hyperplasia. These results thus indicate that specific glycosaminoglycan changes occur in hepatocellular carcinoma, and suggest for the first time that proteoglycan metabolism is also altered in the non-cirrhotic, hepatic parenchyma adjacent to liver carcinoma.     

组蛋白去乙酰化酶抑制剂影响的代谢相关基因的组学筛查及验证

组蛋白去乙酰化酶(Histone deacetylases, HDACs)催化组蛋白去乙酰化,与细胞增殖、分化及凋亡等诸多过程密切相关。HDAC抑制剂(HADC inhibitors, HADCIs)具有潜在的抗肿瘤作用,是近年药物筛查的热点之一。近期研究提示HDAC2可通过影响细胞代谢过程发挥抗肿瘤作用,但各类HDACIs调控代谢过程的机制尚待研究。本研究以肝细胞系(HepG2)为研究对象,整合比较了两种HDACIs(TSA和SAHA)的表达谱数据。在TSA处理组中,筛查到380个差异表达基因(DEGs)及35个DEGs富集的KEGG通路;SAHA处理组的表达分析印证了大多数DEGs(177/380)和富集通路(23/35)。比较分析发现,在这两类HDACIs共同影响的通路中,近一半通路(9/23)与代谢有关;近1/3共享DEGs(66/177)参与代谢过程。通过HDAC2 siRNA细胞实验证实了TSA和SAHA对代谢基因的影响。本研究结果显示HDACIs在治疗肿瘤等代谢性疾病方面具有潜在的应用 价值。     

Proteome analysis of hepatocellular carcinoma

Development of hepatocellular carcinoma (HCC) is a complex process involving multiple changes in gene expression and usually occurs in the presence of liver cirrhosis. In this research, we observed proteome alterations of three tissue types isolated from livers of HCC patients: normal, cirrhotic, and tumorous tissue. Proteome alterations were observed using two-dimensional polyacrylamide gel electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Comparing the tissue types with each other, a significant change in expression level was found in 21 proteins. Of these proteins, sarcosine dehydrogenase, liver carboxylesterase, peptidyl-prolyl isomerase A, and lamin B1 are considered novel HCC marker candidates. In particular, lamin B1 may be considered as a marker for cirrhosis, because its expression level changes considerably in cirrhotic tissue compared with normal tissue. The proteins revealed in this experiment can be used in the future for studies pertaining to hepatocarcinogenesis, or as diagnostic markers and therapeutic targets for HCC.     

Dynamic metabolic change is indicative of inflammation-induced transformation of hepatic cells

The observation that prolonged inflammation plays a causative role in cancer development has been well documented. However, an incremental process that leads from healthy to malignant phenotypes has not yet been described. Experimentally induced hepatocellular carcinoma is considered one of the representative laboratory models for studying this process. Hepatic exposure to viral infection or toxic reagents leads to chronic inflammation and gradual transformation into hepatocellular carcinoma. Here we present metabolomic profiles of hepatic cells at different stages during inflammation-induced cellular transformation by N-nitrosodiethylamine. Using gas chromatography–mass spectrometry, we quantitatively assessed the changes in cellular metabolites during the transformation process in hepatitis and liver cirrhosis. Further pathway analysis of the differentially expressed metabolites showed that carbohydrate metabolism and lipid metabolism were greatly altered in hepatitis and liver cirrhosis, respectively. Additionally, the enhanced inflammation in cirrhosis was associated with a shift from carbohydrate metabolism to lipid and amino acid metabolism. Among the differentially expressed metabolites found in diseased mouse livers, d-glucose and d-mannitol showed the most significant changes, highlighting them as potential early-diagnostic biomarkers of hepatocellular carcinoma development. Taken together, these investigations into the dynamic metabolic changes that occur during the precancerous stages of hepatocellular carcinoma add to and refine understanding of how chronic inflammation ultimately leads to cancer. Furthermore, the findings set the stage for identifying metabolites that may serve as early-diagnostic indicators of these unfolding events.     

Immobilization of active human carboxylesterase 1 in biomimetic silica nanoparticles

The encapsulation of proteins in biomimetic silica has recently been shown to successfully maintain enzymes in their active state. Organophosphate (OP) compounds are used as pesticides as well as potent chemical warfare nerve agents. Because these toxicants are life threatening, we sought to generate biomimetic silicas capable of responding to OPs. Here, we present the silica encapsulation of human drug metabolism enzyme carboxylesterase 1 (hCE1) in the presence of a range of catalysts. hCE1 was successfully encapsulated into silica particles when lysozyme or the peptide R5 were used as catalysts; in contrast, polyethyleneimine, a catalyst used to encapuslate other enzymes, did not facilitate hCE1 entrapment. hCE1 silica particles in a column chromatography format respond to the presence of the OP pesticides paraoxon and dimethyl-p-nitrophenyl phosphate in solution. These results may lead to novel approaches to detect OP pesticides or other weaponized agents that bind hCE1.